Die Information für Ärzte und Apotheker
Neutral, unabhängig und anzeigenfrei
arznei-telegramm® 06/2018
vorherige Ausgabe

NEW ON THE MARKET
Inactivated zoster vaccine SHINGRIX
Me too: SGLT2 inhibitor ertugliflozin (in STEGLUJAN)

a-t READERS QUESTIONS AND COMMENTS
Statins: “treat-to-target” or “fire-and-forget” strategies – What is new?
Parecoxib (DYNASTAT) against postoperative pain?

IN BRIEF
Confirmed: no analgesics alone for uncomplicated cystitis

CURRENT ADR NETWORK REPORT
Hearing loss with secukinumab (COSENTYX)?  free article 

SIDE EFFECTS
Hypersensitivity reactions to flurbiprofen throat drugs
Dietary supplement kratom: FDA warns against fatal risks
Increased risk of secondary cancer with denosumab (XGEVA)
Neural tube defects with dolutegravir (TIVICAY, in TRIUMEQ)
© 2018 arznei-telegramm